Your browser version may not work well with NCBI's Web applications. More information here...
1: Curr Opin Investig Drugs. 2005 May;6(5):537-44.Links

Fontolizumab Protein Design Labs.

francisj_dumont@yahoo.com

Protein Design Labs is developing fontolizumab, a humanized anti-interferon gamma monoclonal antibody, for the potential treatment of autoimmune diseases. By February 2003, the company was actively seeking to outlicense the development and commercialization rights to fontolizumab outside of the US and Canada.

PMID: 15912969 [PubMed - indexed for MEDLINE]

Patient Drug Information

Recent Activity